The FTC’s bid to block the private equity firm’s acquisition of Surmodics claims the tie-up would reduce competition in the ...

Private equity’s GTCR is selling Vernon Hills-based Antylia Scientific, a maker of molecular diagnostic reagents, specialty ...

Brookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion.

Private equity firm GTCR has sold Antylia Scientific to Brookfield Asset Management ’s private equity business and Caisse de ...

Private equity firm GTCR is set to return more than $5 billion to its investors in the calendar year, a source familiar with the matter told Reuters on Thursday, after a string of strong exits sealed ...

Private equity firm GTCR has reached an agreement to offload ITEL Laboratories (itel) to Nearmap, a portfolio company of ...

GTCR, a leading private equity firm, announced that it has signed a definitive agreement to sell ITEL Laboratories, Inc. ("itel" or "the Company"), a leading provider of data and analytics to the P&C ...

Private equity firm GTCR, in collaboration with existing investor Synova, has agreed to acquire UK-based insurance broker JMG Group.   In a statement announcing the move, the broker said it secured ...

Thoma Bravo-backed Nearmap has agreed to buy insurance technology provider itel from private equity firm GTCR, the companies ...

Sale of Industry-Leading Payments Technology and Solutions Company Marks an Important Milestone in GTCR's Strategic Transformation in Partnership with Leaders Strategy™ CEO Charles Drucker ...

The private-equity firm GTCR has agreed to sell a big stake in Ultimus Fund Solutions that values the administrative-services provider at nearly $2 billion, according to people familiar with the ...